IRIS
SANTORO, Vincenza
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 572
EU - Europa 492
AS - Asia 102
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 571
SE - Svezia 170
IE - Irlanda 169
CN - Cina 71
DE - Germania 35
UA - Ucraina 32
IT - Italia 24
FI - Finlandia 20
PL - Polonia 18
SG - Singapore 13
GB - Regno Unito 11
IN - India 11
BE - Belgio 4
NL - Olanda 4
FR - Francia 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
KR - Corea 2
PH - Filippine 2
VN - Vietnam 2
BR - Brasile 1
EU - Europa 1
KZ - Kazakistan 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 1.175
Salva come PNG Salva come JPEG
Città #
Dublin 169
Chandler 160
Nyköping 85
Jacksonville 65
Ashburn 55
Beijing 34
Dearborn 26
Medford 22
Princeton 22
Ann Arbor 20
Warsaw 18
Cambridge 17
Boardman 15
Des Moines 13
Messina 12
Bremen 11
Hyderabad 9
Lancaster 8
Los Angeles 8
Jinan 6
New York 6
Singapore 6
Washington 5
Brussels 4
Enschede 4
Hangzhou 4
Nanjing 4
Ningbo 3
Seattle 3
Shenyang 3
Wilmington 3
Woodbridge 3
Canberra 2
Dong Ket 2
Dongjak-gu 2
Hebei 2
Helsinki 2
Livorno 2
Munich 2
Nanchang 2
Norwalk 2
Pune 2
Rome 2
Santiago 2
Tianjin 2
Zurich 2
Auckland 1
Bordeaux 1
Changsha 1
Ciudad Victoria 1
Enna 1
Fantina 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Guangzhou 1
Haikou 1
Jiaxing 1
Kunming 1
Lappeenranta 1
Manila 1
Mineo 1
Monmouth Junction 1
Oral 1
Palermo 1
Phoenix 1
Santana de Parnaiba 1
Strasbourg 1
Taizhou 1
Ugong Norte 1
Xiangfen 1
Zhengzhou 1
Totale 877
Salva come PNG Salva come JPEG
Nome #
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 85
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 67
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 64
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 63
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 62
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 61
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 60
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 58
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 57
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 56
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 55
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 52
Interactions between antiepileptics and second generation antipsychotics 52
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 51
Effect of adjunctive duloxetine treatment on the plasma concentrations of clozapine, olanzapine and risperidone in patients with psychotic disorders 51
Effect of valproate on plasma concentrations of olanzapine in patients with psychotic disorders , July, 2009, MP 110.. 51
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 50
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 44
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 42
Vortioxetine on Cognition in Schizophrenia: A Pilot Study 36
Drug dosage individualization based on a random-effects linear model 34
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 31
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 19
Totale 1.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 0 0 5 0 21 25 12 2 23 23 2
2020/2021149 14 1 38 15 8 15 6 8 8 16 10 10
2021/2022154 6 5 0 2 5 1 10 7 4 46 14 54
2022/2023515 40 65 24 48 47 47 3 33 190 4 12 2
2023/2024153 6 23 12 12 18 29 3 11 8 14 3 14
2024/202515 1 7 7 0 0 0 0 0 0 0 0 0
Totale 1.201